Addus HomeCare Corporation

Valuation Analysis

About the Company

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health. Its Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as

Addus HomeCare Corporation Stock at a Glance

Addus HomeCare Corporation (ADUS) is currently trading at $93.28 with a market capitalization of $1.7B. The trailing P/E ratio stands at 17.21x, with a forward P/E of 12.48x. The 52-week range spans from $87.95 to $124.44; the current price is 25% below the yearly high. Year-over-year revenue growth stands at +7.7%. The net profit margin stands at 6.89%.

💰 Dividend

Addus HomeCare Corporation currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.

📊 Analyst Rating

13 analysts rate Addus HomeCare Corporation (ADUS) on consensus: None. The average price target is $132.69, implying +42.25% from the current price. Analyst price targets range from $92.00 to $155.00.

Addus HomeCare Corporation: The Investment Case in Detail

Addus HomeCare Corporation (ADUS) operates in the Healthcare — specifically Medical Care Facilities — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

The Bull Case

Our valuation screen flags the stock as undervalued relative to its fundamentals — multiples are running below where the cash flow profile would normally justify.

Valuation in Context

With a PEG ratio of 0.9, the price-to-earnings multiple is actually below the company's growth rate — classic value-meets-growth territory that Peter Lynch would have called a 'GARP' opportunity.

What to Watch Next

• The forward P/E of 12.48x is meaningfully below the trailing 17.21x — analysts expect earnings to step up; the next earnings release is the test.
• The price sits in the lower quartile of the 52-week range — value hunters often start scaling in around this zone if fundamentals hold.
• The analyst consensus price target implies 42.25% upside — if the next two quarters confirm the underlying thesis, target hikes typically follow.

Investment Thesis: Strengths & Weaknesses

Technical Snapshot

Price is below both the 50- and 200-day moving averages, with 50d below 200d — a bearish picture (death-cross alignment).

Risk Profile

The data points to relatively defensive market behavior, elevated short interest (6.21%).

Trading Data

Related Stocks in the Same Sector

Where can I buy Addus HomeCare Corporation?

Compare top-rated brokers — low fees, trusted providers, fully regulated.